Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	144.71	69.33	75.05	93.12	203.43	288.64
Short-Term Investments	377.89	384.28	179.82	368.21	136.25	133.89
Cash & Short-Term Investments	522.6	453.61	254.87	461.33	339.68	422.53
Cash Growth	50.52%	77.98%	-44.75%	35.81%	-19.61%	21.74%
Accounts Receivable	140.83	142.08	144.16	165.5	148.93	140.88
Inventory	44.02	54.29	77.41	91.54	85.96	48.33
Other Current Assets	31.42	36.09	16.68	15.78	27.02	18.68
Total Current Assets	738.87	686.07	493.11	734.15	601.59	630.42
Net Property, Plant & Equipment	11.07	11.55	13.53	15.17	16.96	37.82
Other Intangible Assets	481.31	521.91	599.89	702.46	784.69	364.34
Goodwill	117.02	117.02	117.02	117.02	117.52	77.91
Long-Term Investments	-	-	16.62	93.9	119.17	350.36
Other Long-Term Assets	34.14	31.53	37.51	39.81	49.23	43.25
Total Assets	1,382	1,368	1,278	1,703	1,689	1,504
Accounts Payable	77.74	76.35	79.57	96.34	117.68	78.93
Accrued Expenses	180.92	168.71	154.27	151.67	132.72	126.19
Short-Term Debt	-	-	-	401.97	-	-
Other Current Liabilities	27.71	47.34	56.35	37.98	64.97	39.98
Total Current Liabilities	286.36	292.4	290.2	687.96	315.38	245.11
Long-Term Debt	-	-	-	-	379.25	361.75
Long-Term Leases	24.38	27.38	33.2	36	41.3	28.58
Other Long-Term Liabilities	7.76	12.56	32.77	92.35	137.37	123.81
Total Long-Term Liabilities	32.15	39.94	65.96	128.35	557.92	514.14
Total Liabilities	318.51	332.34	356.16	816.3	873.3	759.24
Common Stock	0.06	0.06	0.06	0.05	0.05	0.05
Additional Paid-in Capital	496.95	479.44	439.49	408.12	434.34	409.33
Accumulated Other Comprehensive Income	-0.2	-0.19	-0.59	-3.21	1.54	8.98
Retained Earnings	567.1	556.43	482.56	481.25	379.92	326.5
Shareholders' Equity	1,064	1,036	921.52	886.2	815.85	744.86
Total Liabilities & Equity	1,382	1,368	1,278	1,703	1,689	1,504
Total Debt	24.38	27.38	33.2	437.97	420.55	390.33
Net Cash (Debt)	498.21	426.23	221.68	23.37	-80.87	32.2
Net Cash Growth	16.89%	92.27%	848.64%	-	-	-
Net Cash Per Share	8.86	7.62	3.99	0.38	-1.49	0.60
Book Value	1,064	1,036	921.52	886.2	815.85	744.86
Book Value Per Share	18.91	18.51	16.60	14.37	15.01	13.87
Tangible Book Value	465.57	396.8	204.61	66.72	-86.36	302.61
Tangible Book Value Per Share	8.28	7.09	3.69	1.08	-1.59	5.64

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q